AC Immune (ACIU) EBT Margin Growth (3y) (2018 - 2025)

AC Immune (ACIU) EBT Margin Growth (3y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 AC Immune 225.68 Mn 225.68 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -134,236.00
Sep 30, 2022 -117,433.00
Dec 31, 2020 -209,542.00
Sep 30, 2020 -81,206.00
Jun 30, 2020 8,769.00
Mar 31, 2020 -6,214.00
Dec 31, 2019 -311,638.00
Sep 30, 2019 152,802.00
Mar 31, 2019 135,269.00
Dec 31, 2018 -132,402.00
Sep 30, 2018 -66,884.00